Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411039200 on October 26, 2004

J. Biol. Chem., Vol. 280, Issue 1, 571-577, January 7, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/1/571    most recent
M411039200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruan, B.
Right arrow Articles by Söll, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruan, B.
Right arrow Articles by Söll, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Unique Hydrophobic Cluster Near the Active Site Contributes to Differences in Borrelidin Inhibition among Threonyl-tRNA Synthetases*

Benfang Ruan{ddagger}, Michael L. Bovee§, Meik Sacher{ddagger}, Constantinos Stathopoulos{ddagger}, Karl Poralla||, Christopher S. Francklyn§**, and Dieter Söll{ddagger}{ddagger}{ddagger}§§

From the {ddagger}Departments of Molecular Biophysics and Biochemistry and {ddagger}{ddagger}Chemistry, Yale University, New Haven, Connecticut 06520-8114, §Department of Biochemistry, The University of Vermont Health Sciences Complex, Burlington, Vermont 05405-0068, and ||Institut für Mikrobiologie, Eberhardt-Karls-Universität Tübingen, Auf der Morgenstelle 28, D-72076 Tübingen, Germany

Borrelidin, a compound with anti-microbial and anti-angiogenic properties, is a known inhibitor of bacterial and eukaryal threonyl-tRNA synthetase (ThrRS). The inhibition mechanism of borrelidin is not well understood. Archaea contain archaeal and bacterial genre ThrRS enzymes that can be distinguished by their sequence. We explored species-specific borrelidin inhibition of ThrRSs. The activity of ThrRS from Sulfolobus solfataricus and Halobacterium sp. NRC-1 was inhibited by borrelidin, whereas ThrRS enzymes from Methanocaldococcus jannaschii and Archaeoglobus fulgidus were not. In Escherichia coli ThrRS, borrelidin binding induced a conformational change, and threonine was not activated as shown by ATP-PPi exchange and a transient kinetic assay measuring intrinsic tryptophan fluorescence changes. These assays further showed that borrelidin is a noncompetitive tight binding inhibitor of E. coli ThrRS with respect to threonine and ATP. Genetic selection of borrelidin-resistant mutants showed that borrelidin binds to a hydrophobic region (Thr-307, His-309, Cys-334, Pro-335, Leu-489, Leu-493) proximal to the zinc ion at the active site of the E. coli ThrRS. Mutating residue Leu-489 -> Trp reduced the space of the hydrophobic cluster and resulted in a 1500-fold increase of the Ki value from 4 nM to 6 µM. An alignment of ThrRS sequences showed that this cluster is conserved in most organisms except for some Archaea (e.g. M. jannaschii, A. fulgidus) and some pathogens (e.g. Helicobacter pylori). This study illustrates how one class of natural product inhibitors affects aminoacyl-tRNA synthetase function, providing potentially useful information for structure-based inhibitor design.


Received for publication, September 27, 2004 , and in revised form, October 26, 2004.

* This work was supported by grants from the National Institute of General Medical Sciences (to D. S. and C. S. F.) and the Department of Energy (to D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Current address: Dept. of Biochemistry and Biotechnology, University of Thessaly, 41221 Larissa, Greece.

** To whom correspondence may be addressed: Dept. of Biochemistry, University of Vermont Health Sciences Complex, Burlington, VT 05405-0068. Tel.: 802-656-8450; Fax: 802-862-8229; E-mail: franck{at}emba.uvm.edu.

§§ To whom correspondence may be addressed: Dept. of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8114. Tel.: 203-432-6200; Fax: 203-432-6202; E-mail: soll{at}trna.chem.yale.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. G. Hurdle, A. J. O'Neill, and I. Chopra
Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents
Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4821 - 4833.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement